Position in AMGN
as of Jun 30, 2026
· filed Jul 10, 2026
Position Value
$3,608,887
+$618,866 QoQ
Shares Held
9,966
+17.3% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.78%
of 13F equity value
Holder Rank
#980
of 3,140 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Generali Investments, Management Co LLC holds $49,014,742 across 9 Drug Manufacturers - General names. AMGN ranks #6 (7.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
10,220 | $12,258,175 | |
| 2 | JNJ |
Johnson & Johnson
|
32,881 | $8,350,787 | |
| 3 | MRK |
Merck & Co., Inc.
|
58,747 | $7,548,989 | |
| 4 | ABBV |
AbbVie Inc.
|
29,767 | $7,490,567 | |
| 5 | PFE |
Pfizer Inc
|
189,601 | $4,565,592 | |
| 6 | AMGN |
Amgen Inc
This page
|
9,966 | $3,608,887 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
20,496 | $2,589,464 | |
| 8 | BIIB |
Biogen Inc.
|
7,437 | $1,606,838 |
All Filings in AMGN
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,608,887 | 9,966 | Shares | Sole | 2026-07-10 | |
| 2026-03-31 | $2,990,021 | 8,498 | Shares | Sole | 2026-04-09 | |
| 2025-12-31 | $2,899,639 | 8,859 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $2,162,498 | 7,663 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $1,728,868 | 6,192 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $2,021,024 | 6,487 | Shares | Sole | 2025-04-11 | |
| 2024-12-31 | $1,669,138 | 6,404 | Shares | Sole | 2025-02-11 | |
| No filing history on record for this holder in this stock. | ||||||